| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/21/2004 | CN1513451A Traditional chinese medicine Monascus purpureus went using Lovastatin salt as main active and its preparation component |
| 07/21/2004 | CN1513450A Injection of compound pancreatic alcohol |
| 07/21/2004 | CN1513449A Prepn. method for injection of ginkgolide |
| 07/21/2004 | CN1513448A Prepn. of medicine composition contg. garcinolic acid and garcinolic acid compound |
| 07/21/2004 | CN1513447A Application of bamboo leaf total flavone in medicine for treating and preventing prostata disease and health-care-food |
| 07/21/2004 | CN1513446A Injection of sodium bouttuynin, and its prepn. method |
| 07/21/2004 | CN1513445A Sodium bouttuynin small pellet, and its prepn. method |
| 07/21/2004 | CN1513444A Medicine for treating metaboic syndrome |
| 07/21/2004 | CN1513443A Large volume injection of lysine glucose hydrochloride, and its prepn. method |
| 07/21/2004 | CN1513442A Prepn. and use of mixture of arginine-burfenum |
| 07/21/2004 | CN1513441A Injection of diisoprapylamine dichloropacetate for treating liver function damage, and its prepn. technique |
| 07/21/2004 | CN1513439A Slow release medicine of pseudo-ephedrine hydrochloride |
| 07/21/2004 | CN1158301C Soluble inorganic salt of Huanweihuangyangxing D, its preparing process and medicine conaining it |
| 07/21/2004 | CN1158299C Substituted 4-benzylaminoquinoline, method for producing the same, medicaments containing these compounds and their use |
| 07/21/2004 | CN1158298C Antineoplastic compound and its prepn and medicine use |
| 07/21/2004 | CN1158297C Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/21/2004 | CN1158290C Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 07/21/2004 | CN1158287C Benzothieno [3,2-c] pyridines as alpha 2-antagonists |
| 07/21/2004 | CN1158286C Taxane derivatives and processes for preparation thereof |
| 07/21/2004 | CN1158284C Porphyrins and their use |
| 07/21/2004 | CN1158283C 4,5-pyrazinoxindoles as protein kinase inhibitors |
| 07/21/2004 | CN1158282C Camptothecine like compound, its preparing method and medicinal composition containing them |
| 07/21/2004 | CN1158279C 1-(P-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for production and utilization thereof and pharmaceutical preparations containing said compounds |
| 07/21/2004 | CN1158277C Farnesyl transferase inhibitors having piperidine structure and process for preparation thereof |
| 07/21/2004 | CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 07/21/2004 | CN1158275C Method of preparing delta-9-tetrahydrocannabinol esters |
| 07/21/2004 | CN1158274C Benzopyran-containing compounds and method for their use |
| 07/21/2004 | CN1158272C Substituted benzodihydropyranyl sulfonylurea, its preparation, use in medicines and medicines containing the same |
| 07/21/2004 | CN1158269C 4-aminothiazole 2 group compound as inhibitors of cyclin-dependent kinases |
| 07/21/2004 | CN1158266C Compounds |
| 07/21/2004 | CN1158265C Quinoline ketone derivant and antianaphylaction using same as active substance |
| 07/21/2004 | CN1158264C Metabotropic glutamate receptor antagonists for treating central nervous system disease |
| 07/21/2004 | CN1158261C Antivirals |
| 07/21/2004 | CN1158260C Solid compound, preparation method therefor and use in medicine |
| 07/21/2004 | CN1158259C Potassium channel openers |
| 07/21/2004 | CN1158258C Alpha 1 beta-adrenergic receptor antagonists |
| 07/21/2004 | CN1158257C Novel amino pyrroline compound, its prepn. method and pharmaceutical compositions contg. same |
| 07/21/2004 | CN1158256C Pyrrolidine derivatives-CCR-3 receptor antagonists |
| 07/21/2004 | CN1158206C Hormone replacement therapy method and hormone dispenser |
| 07/21/2004 | CN1158109C Biologically composite artificial bone and its preparing process |
| 07/21/2004 | CN1158107C Pharmaceutical compositions contg. platelet aggregation inhibitors |
| 07/21/2004 | CN1158104C Chinese medicine preparation for treating acute condyloma |
| 07/21/2004 | CN1158103C Medicine for treating archosyrinx and its preparation method |
| 07/21/2004 | CN1158099C Medicine for treating osteoarthritis and its preparing process and application |
| 07/21/2004 | CN1158097C Medicine for treating anal disease and its prepn |
| 07/21/2004 | CN1158090C Medicine for treating psoriasis |
| 07/21/2004 | CN1158089C Detoxicating and hypolipemic capsule |
| 07/21/2004 | CN1158084C Long-acting heparin intraocular slow-released system |
| 07/21/2004 | CN1158083C Nucleic acid oral liquid for animals and its preparing process |
| 07/21/2004 | CN1158082C Pharmaceutical usage of diosgenin |
| 07/21/2004 | CN1158081C Medicine composition containing active vitamin D compound and its use |
| 07/21/2004 | CN1158080C Application of ligustrazine and aminoguanidin in treating II-type diabetes and its complication |
| 07/21/2004 | CN1158079C Compound alkyl camptothecine injection prescription and prepn. process thereof |
| 07/21/2004 | CN1158078C 复方东莨菪碱 Compound scopolamine |
| 07/21/2004 | CN1158077C New application of benzene ring pelargonate hydrochloride |
| 07/21/2004 | CN1158076C Thrombolytic injection for curing cerebral infarction or cerebral thrombus |
| 07/21/2004 | CN1158075C Pharmaceutical compsn. and process for its prepn. |
| 07/21/2004 | CN1158074C Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 07/21/2004 | CN1158073C Application of protein kinase C inhibitor in preparing medicine |
| 07/21/2004 | CN1158072C Granulate with high content of L-carnitine or alkanoyl L-carnitine suitable for preparing tablets by pressing directly |
| 07/21/2004 | CN1158071C Multi-layered osmotic device |
| 07/21/2004 | CN1158070C Immediate release tablet |
| 07/21/2004 | CN1158069C Antibacterial oil-in-water emulsions |
| 07/21/2004 | CN1158062C Aerosol hair spray compositions comprising combinations of polysiloxane grafted copolymers |
| 07/21/2004 | CN1158055C Silk clothes for protecting affected parts |
| 07/20/2004 | USRE38558 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| 07/20/2004 | US6765105 Compound and pharmaceutical composition of antiplasmid effect and the preparation thereof |
| 07/20/2004 | US6765104 Transition metal complexes of n, n',n″trialkyl-cis-1,3,5-triaminocyclohexane and related compositions and methods of synthesis and use |
| 07/20/2004 | US6765096 Antiallergic agent, immunosuppressant |
| 07/20/2004 | US6765095 2,3-disubstituted pyridine derivative, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
| 07/20/2004 | US6765022 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists |
| 07/20/2004 | US6765021 Antidiabetic agents |
| 07/20/2004 | US6765020 Drugs for prevention and treatment of diseases caused by abnormalities in cartilage tissues |
| 07/20/2004 | US6765019 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 07/20/2004 | US6765016 11,12-cyclized erythromycin derivative bactericides |
| 07/20/2004 | US6765014 1-Acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors |
| 07/20/2004 | US6765013 Thiazolidinedione derivatives for the treatment of diabetes and other diseases |
| 07/20/2004 | US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
| 07/20/2004 | US6765011 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 07/20/2004 | US6765010 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
| 07/20/2004 | US6765008 Pyrrolopyrimidines as CRF antagonists |
| 07/20/2004 | US6765007 High-content famciclovir tablets |
| 07/20/2004 | US6765006 Antagonists of amino-3-hydroxy-5-methylisoxazole-4-propionic acid (ampa) ionotropic receptors; neurodegenerative, alzheimer's, and huntington's disease; amyotrophic lateral sclerosis; schizophrenia, excitatory amino acid deficiency |
| 07/20/2004 | US6765005 Fab I inhibitors |
| 07/20/2004 | US6765004 Anticoagulants, antiischemic and hypotensive agents; cardiovascular disorders, congestive heart failure, liver cirrhosis, renal vasospasm, renal failure, cerebral edema and ischemia, strokes |
| 07/20/2004 | US6765003 3-Arylsulfonyl-2 (substituted methyl) propanoic acid derivatives as matrix metalloproteinase inhibitors |
| 07/20/2004 | US6765002 Preventing the development of epithelial ovarian cancer by administering compounds in an amount capable of increasing tgf- beta expression in the ovarian epithelium. hrt and ocp regimens comprising such compositions and methods are |
| 07/20/2004 | US6765001 Mixture with penetration intensifiers, solvents and emulsifiers |
| 07/20/2004 | US6765000 For therapy of symptoms associated in humans with reactive arthritis (spondyloarthritity) or idiopathic bursitis |
| 07/20/2004 | US6764999 Administering ivermectin, milbemycin or avermectin compounds in propylene glycol to increase animal's blood levels |
| 07/20/2004 | US6764997 Admixture of azithromycin and a stabilizing-effective amount of an antioxidant to improve the resistance of the azithromycin to degradation; for therapy of bacterial infection in a human or non- human animal |
| 07/20/2004 | US6764996 Bactericides for infections |
| 07/20/2004 | US6764698 Controlled drug release system of retinoic acid |
| 07/20/2004 | US6764697 Hydroxyethylcellulose layer allows drug-free period; angina therapy; administering hypotensive agent |
| 07/20/2004 | US6764693 Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants |
| 07/20/2004 | US6764692 Administering naturally chelated trace mineral for healthy skin, hair and hoof tissue |
| 07/20/2004 | US6764683 Stimulation of hematopoiesis in patients undergoing cytotoxic cancer chemotherapy; preventing mucositis; cytoprotection |
| 07/20/2004 | US6764678 Local anesthetic methods and kits |
| 07/20/2004 | US6763747 Shock absorbing hammer and handle assembly |